Krystal Biotech (KRYS)

Krystal Biotech (KRYS) Financial Statements


Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently ―. The company's EPS TTM is $-5.503; its P/E ratio is -13.55; Krystal Biotech is scheduled to report earnings on May 8, 2023, and the estimated EPS forecast is $-1.44. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -32.05M$ -29.85M$ -28.11M$ -49.97M$ -21.81M
EBITDA$ -30.96M$ -28.88M$ -27.13M$ -48.95M$ -21.02M
Net Income Common Stockholders$ -32.05M$ -29.85M$ -28.11M$ -49.97M$ -21.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 379.17M$ 394.42M$ 425.56M$ 434.63M$ 438.10M
Total Assets$ 558.45M$ 576.38M$ 601.32M$ 616.87M$ 626.29M
Total Debt$ 8.93M$ 9.12M$ 9.13M$ 9.29M$ 8.02M
Net Debt$ -370.24M$ -385.30M$ -416.43M$ -425.34M$ -430.07M
Total Liabilities$ 36.22M$ 35.61M$ 42.14M$ 68.32M$ 32.72M
Stockholders Equity$ 522.23M$ 540.77M$ 559.18M$ 548.55M$ 593.58M
Cash Flow-
Free Cash Flow$ -27.55M$ -33.74M$ -59.57M$ -32.68M$ -61.78M
Operating Cash Flow$ -22.33M$ -19.69M$ -43.06M$ -15.49M$ -20.90M
Investing Cash Flow$ -5.21M$ -14.74M$ -38.22M$ -55.91M$ -126.54M
Financing Cash Flow$ 3.07M$ 2.12M$ 30.70M$ -542.00K$ 202.07M
Currency in USD

Krystal Biotech Earnings and Revenue History

Krystal Biotech Debt to Assets

Krystal Biotech Cash Flow

Krystal Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis